Enzene Launches NeX™ Partnership Model to Boost Local Biomanufacturing in India

Pune-based Enzene, a global biomanufacturing organization, officially launched its NeX™ partnership model on August 4, 2026. This initiative is designed to provide an end-to-end solution for local biomanufacturing, aiming to make the production of complex biologics more cost-efficient and accessible. By leveraging advanced technology, the model seeks to empower governments and institutions to build robust local manufacturing capabilities.

The NeX™ model focuses on high-yielding production processes that can be deployed locally, reducing dependency on international supply chains. This is particularly relevant for India, where the demand for affordable biopharmaceuticals is rising. Enzene’s approach aligns with broader national goals to strengthen the domestic healthcare ecosystem and ensure a steady supply of essential medicines for the growing population.

This launch comes at a time when India is actively working to overhaul its health research and manufacturing landscape. With the upcoming India Medical Device 2026 conference and the recent draft National Health Research Policy, the introduction of such innovative models is expected to play a pivotal role in shaping the future of the Indian MedTech and biopharma sectors. The initiative is poised to attract further investment and foster collaboration between public and private stakeholders.